National Evaluation of the DP18-1815 Cooperative Agreement Program: Category B, Cardiovascular Disease Prevention and Management

Forms and Documents

Document Name	Status
Cost Study Resource Use and Cost Inventory Tool – Partner/Site Level Form and Instruction	New
CCL Partner Site-Level Informant Interview Form and Instruction	New
MTM Partner Site-Level Interview Form and Instruction	New
TBC Partner Site-Level Interview Form and Instruction	New
CQM Partner Site-Level Interview Form and Instruction	New
Recipient-Led Evaluation Annual Report Template Form and Instruction	New
Cost Study Resource Use and Cost Study Inventory Tool - Health Departments Form and Instruction	New
CCL Group Discussion Form and Instruction	New
CCL Health Department Interview Form and Instruction	New
TBC Group Discussion Form and Instruction	New
MTM Health Department Interview Form and Instruction	New
TBC Health Department Interview Form and Instruction	New
CQM Group Discussion Form and Instruction	New
CQM Health Department Interview Form and Instruction	New
Att 9e. Cat B Case Study Follow Up Email.docx Supplementary Document	2020-05-05
Att 9d. Cat B Case Study Rem Email.docx Supplementary Document	2020-05-05
Att 9c. Cat B Case Study Confirm Email.docx Supplementary Document	2020-05-05
Att 9b. Cat B Case Study Partner Site Invite.docx Supplementary Document	2020-05-05
Att 9a. Cat B Case Study HD Invite_rev.docx Supplementary Document	2020-12-02
Att 8b. Inst Rev Board App Not_Exemp Det_Pt B.PDF Supplementary Document	2020-05-05
Att 8a. Inst Rev Board App Not_Exemp Det_Pt A.pdf Supplementary Document	2020-05-05
Att 7. 60-day FRN.pdf Supplementary Document	2020-05-05
Att 3f. Cat B 1815 Eval Gantt Chart.xlsx Supplementary Document	2020-05-05
Att 3e. Cat B 1815 Summ of Annual Resp.docx Supplementary Document	2020-05-05
Att 3d. Cat B Crosswalk Eval Comp_Data Coll Tools.docx Supplementary Document	2020-05-05
Att 3c. 1815 Logic Model.docx Supplementary Document	2020-05-05
Att 3b. 1815 Strat Prev_Control.docx Supplementary Document	2020-05-05
Att 3a. 1815 List of HD Awardees.docx Supplementary Document	2020-05-05
Att 2. Auth Leg Sec 301a of PH Serv Act.pdf Supplementary Document	2020-05-05
Att 1. CDC-RFA-DP18-1815PPHF18.pdf Supplementary Document	2020-05-05
SSB_1815 Category B_v06_rev.docx Supporting Statement B	2020-12-02
SSA_1815 Category B_v06_rev.docx Supporting Statement A	2020-12-02

IC Document Collections

IC ID	Document Title	Status
241440	Cost Study Resource Use and Cost Inventory Tool – Partner/Site Level Form and Instruction	New
241439	CCL Partner Site-Level Informant Interview Form and Instruction	New
241438	MTM Partner Site-Level Interview Form and Instruction	New
241436	TBC Partner Site-Level Interview Form and Instruction	New
241435	CQM Partner Site-Level Interview Form and Instruction	New
241434	Recipient-Led Evaluation Annual Report Template Form and Instruction	New
241433	Cost Study Resource Use and Cost Study Inventory Tool - Health Departments Form and Instruction	New
241432	CCL Group Discussion Form and Instruction	New
241431	CCL Health Department Interview Form and Instruction	New
241430	TBC Group Discussion Form and Instruction	New
241428	MTM Health Department Interview Form and Instruction	New
241426	TBC Health Department Interview Form and Instruction	New
241425	CQM Group Discussion Form and Instruction	New
241424	CQM Health Department Interview Form and Instruction	New

ICR Details

OMB Control No: 0920-1311	ICR Reference No: 202003-0920-010
Status: Active	Previous ICR Reference No:
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-20HP
Title: National Evaluation of the DP18-1815 Cooperative Agreement Program: Category B, Cardiovascular Disease Prevention and Management
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved with change	Conclusion Date: 12/03/2020
	Date Received in OIRA: 05/15/2020
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	12/31/2023	36 Months From Approved
Responses	253	0	0
Time Burden (Hours)	743	0	0
Cost Burden (Dollars)	30,515	0	0

---

Abstract: The cooperative agreement, Improving the Health of Americans Through Prevention and Management of Diabetes and Heart Disease and Stroke, supports state investments in implementing and evaluating evidence-based strategies to prevent and manage diabetes and cardiovascular disease (CVD). This information collection request focuses on activities conducted under cooperative agreement Category B: Cardiovascular Disease (CVD) Prevention and Management. The purpose of data collection is to evaluate how states are using CDC DP18-1815 funds to implement evidence-based strategies, and determine how those efforts are contributing to state, health system, or other organization level changes/outcomes related to CVD.

---

Authorizing Statute(s): US Code: 42 USC 241 Name of Law: Public Health Service Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	84 FR 32185	07/05/2019
30-day Notice:	Federal Register Citation:	Citation Date:
	85 FR 29451	05/15/2020
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 14

IC Title	Form No.	Form Name
CQM Health Department Interview	n/a	CQM State Health Department Interview Guide
CQM Group Discussion	n/a	CQM Health Department Group Discussion Guide
TBC Health Department Interview	n/a	TBC Health Department Interview Guide
MTM Health Department Interview	n/a	MTM Health Department Interview Guide
TBC Group Discussion	n/a	TBC Group Discussion Guide
CCL Health Department Interview	n/a	CCL Health Department Interview Guide
CCL Group Discussion	n/a	CCL Health Department Group Discussion Guide
Recipient-Led Evaluation Annual Report Template	n/a, n/a, n/a	Recipient Evalation Year 3 Effectiveness Brief ,   Recipient Evaluation Year 4 Sustainability and Action Report Guidance ,   Recipient Evaluation Year 5 Health Impact Statement
TBC Partner Site-Level Interview	n/a	TBC Partner Site-Level Interview Guide
MTM Partner Site-Level Interview	n/a, n/a	MTM Partner Site Interview Guide ,   MTM Partner Site Interview Guide for Pharmacists
CCL Partner Site-Level Informant Interview	n/a	CCL Partner-Site Key Informant Interview Guide
Cost Study Resource Use and Cost Inventory Tool – Partner/Site Level	n/a	Resource Use and Cost Inventory Tool
Cost Study Resource Use and Cost Study Inventory Tool - Health Departments	n/a	Resource Use and Cost Inventory Tool
CQM Partner Site-Level Interview	n/a	CQM Partner Site-level Interview Guide

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	253	0	0	253	0	0
Annual Time Burden (Hours)	743	0	0	743	0	0
Annual Cost Burden (Dollars)	30,515	0	0	30,515	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: This is a new information collection request.

---

Annual Cost to Federal Government: $1,041,626

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     Yes

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 05/15/2020

---